Furthermore, decreased staining for CD31 and reduced VEGF expression were also observed, suggesting that a combination of IR and ERK5 siRNA could inhibit tumor progression, primarily by suppressing tumor-related angiogenesis. The gene discussed is PECAM1; the disease is neoplasm.